Details for Patent: 10,052,314
✉ Email this page to a colleague
Which drugs does patent 10,052,314 protect, and when does it expire?
Patent 10,052,314 protects ERLEADA and is included in one NDA.
This patent has sixty-seven patent family members in thirty-four countries.
Summary for Patent: 10,052,314
| Title: | Anti-androgens for the treatment of non-metastatic castrate-resistant prostate cancer |
| Abstract: | Described herein are methods of treating non-metastatic castrate-resistant prostate cancer with anti-androgens. |
| Inventor(s): | Chen; Isan (San Diego, CA) |
| Assignee: | Aragon Pharmaceuticals, Inc. (San Diego, CA) |
| Application Number: | 15/851,444 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,052,314 |
|
Patent Claim Types: see list of patent claims | Use; Delivery; |
Drugs Protected by US Patent 10,052,314
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Janssen Biotech | ERLEADA | apalutamide | TABLET;ORAL | 210951-001 | Feb 14, 2018 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | TREATMENT IN COMBINATION WITH A GNRH AGONIST OF NON-METASTATIC, CASTRATION-RESISTANT PROSTATE CANCER (NM-CRPC) | ⤷ Try a Trial | |||
| Janssen Biotech | ERLEADA | apalutamide | TABLET;ORAL | 210951-001 | Feb 14, 2018 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | TREATMENT IN COMBINATION WITH A GNRH AGONIST OF HIGH RISK NON-METASTATIC, CASTRATION-RESISTANT PROSTATE CANCER (NM-CRPC) | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,052,314
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2013323861 | ⤷ Try a Trial | |||
| Australia | 2018206695 | ⤷ Try a Trial | |||
| Australia | 2020244431 | ⤷ Try a Trial | |||
| Brazil | 112015006705 | ⤷ Try a Trial | |||
| Canada | 2885415 | ⤷ Try a Trial | |||
| Chile | 2015000715 | ⤷ Try a Trial | |||
| China | 104661658 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
